Recent from talks
Doping in the United States
Knowledge base stats:
Talk channels stats:
Members stats:
Doping in the United States
Doping, or the use of restricted performance-enhancing drugs in the United States occurs in different sports, most notably in the sports of baseball and football.
As of a 2024 study, 2.2% of U.S. athletes have self-reported to using anabolic steroids, peptide hormones, or blood manipulation. When beta-2 agonist inhalers and marijuana are included, 9.2% of athletes have self-reported themselves as having used in-competition prohibited substances.
The United States has had ten Olympic medals stripped or returned for doping, specifically by Rick DeMont (1972 due to mishandling of medication declaration), Marion Jones (5 medals in 2000), Antonio Pettigrew and Jerome Young (2000), Lance Armstrong (2000), Tyler Hamilton (2004), and Tyson Gay (2012).
According to a 2024 peer-reviewed study published in the journal of Sports Medicine, between 6.5 and 9.2% of US athletes self-reported using one or more prohibited methods in a survey. A 2024 study from the University of Chicago reported a 2.2% doping prevalence rate for use of anabolic steroids, peptide hormones, and blood manipulation. When beta-2 agonist inhalers, marijuana or other in-competition prohibited substances were included, 9.2% of athletes reported themselves as having doped.
Restrictions regarding drug use like synthetic hormones by athletes for enhanced performance in competition did not come around until the 20th century. The International Olympic Committee (IOC) established its initial list of prohibited substances in 1967 and introduced the first drug tests at the France and Mexico Olympic Games in 1968. Thirty years later, the World Anti-Doping Agency (WADA) was founded. WADA was founded at a time when individual governments, sport federations, and the IOC all had differing definitions, policies, and sanctions for doping. WADA bridged these differences by setting unified anti-doping standards and coordinating the efforts of sports organizations and public authorities worldwide.
The United States, a WADA Foundation board member, followed suit by establishing the United States Anti-Doping Agency (USADA) in 2000. USADA is recognized by the United States Congress as the official anti-doping agency for Olympic, Pan American and Paralympic sport in the United States. The agency has adjudication powers and abides by WADA's World Anti-Doping Code ("Code"), which provides the global framework for anti-doping policies, rules, and regulations.[citation needed] Doping in sports is generally defined as using a prohibited / banned substance; however, WADA expanded the definition to include breaking one or more of eight anti-doping rules within the Code, which range from presence of a prohibited substance in an athlete's test sample to administering or attempting to administer a prohibited substance or method to an athlete. As of December 19, 2008, the Code banned 192 performance-enhancing drugs, substances, and methods.
Similar to the definitional disputes the international community faced in the 1990s, national professional sports leagues in the U.S. approach anti-doping policy differently and independently of U.S. government regulation, WADA guidelines, and one another. This is not a big issue for WADA because the athletes participating in these leagues do not compete internationally, i.e. at the Olympics or World Championships. The leagues do not have the same list of banned substances or tests they require players to abide by, may not provide tests or sanctions for use of some prohibited substances, and negotiate their anti-doping policies with their respective players associations through collective bargaining.
In 2005, the United States House Committee on Oversight and Government Reform took an active interest on anti-drug policies in professional sports by opening an investigation into the matter following heightened media activity on steroid use in Major League Baseball (MLB). The use, possession, distribution, dispensing, or selling of steroids is a punishable federal offense under the Controlled Substances Act which, in addition to steroids, lists other performance-enhancing drugs and substances as Schedule III drugs. A series of Schedule III drugs were held, most notably with MLB, the National Football League (NFL), and the National Basketball Association (NBA). Each league's anti-drug policy was compared to that of the IOC, and each fell short of the IOC requirements. Response to the congressional investigation by sports league representatives resulted largely with push back and a "we can police our own" mentality, but the Committee felt differently and introduced the Clean Sports Act, one of six bills introduced that year in both chambers —addressing the need to adopt uniform national anti-drug policy standards among professional sports leagues that are consistent with, and as stringent as, those enforced by the USADA. While most of the bills were voted out of committee, none were enacted. As of 2013, professional sports leagues continue to negotiate their anti-doping policies privately through collective bargaining.
Hub AI
Doping in the United States AI simulator
(@Doping in the United States_simulator)
Doping in the United States
Doping, or the use of restricted performance-enhancing drugs in the United States occurs in different sports, most notably in the sports of baseball and football.
As of a 2024 study, 2.2% of U.S. athletes have self-reported to using anabolic steroids, peptide hormones, or blood manipulation. When beta-2 agonist inhalers and marijuana are included, 9.2% of athletes have self-reported themselves as having used in-competition prohibited substances.
The United States has had ten Olympic medals stripped or returned for doping, specifically by Rick DeMont (1972 due to mishandling of medication declaration), Marion Jones (5 medals in 2000), Antonio Pettigrew and Jerome Young (2000), Lance Armstrong (2000), Tyler Hamilton (2004), and Tyson Gay (2012).
According to a 2024 peer-reviewed study published in the journal of Sports Medicine, between 6.5 and 9.2% of US athletes self-reported using one or more prohibited methods in a survey. A 2024 study from the University of Chicago reported a 2.2% doping prevalence rate for use of anabolic steroids, peptide hormones, and blood manipulation. When beta-2 agonist inhalers, marijuana or other in-competition prohibited substances were included, 9.2% of athletes reported themselves as having doped.
Restrictions regarding drug use like synthetic hormones by athletes for enhanced performance in competition did not come around until the 20th century. The International Olympic Committee (IOC) established its initial list of prohibited substances in 1967 and introduced the first drug tests at the France and Mexico Olympic Games in 1968. Thirty years later, the World Anti-Doping Agency (WADA) was founded. WADA was founded at a time when individual governments, sport federations, and the IOC all had differing definitions, policies, and sanctions for doping. WADA bridged these differences by setting unified anti-doping standards and coordinating the efforts of sports organizations and public authorities worldwide.
The United States, a WADA Foundation board member, followed suit by establishing the United States Anti-Doping Agency (USADA) in 2000. USADA is recognized by the United States Congress as the official anti-doping agency for Olympic, Pan American and Paralympic sport in the United States. The agency has adjudication powers and abides by WADA's World Anti-Doping Code ("Code"), which provides the global framework for anti-doping policies, rules, and regulations.[citation needed] Doping in sports is generally defined as using a prohibited / banned substance; however, WADA expanded the definition to include breaking one or more of eight anti-doping rules within the Code, which range from presence of a prohibited substance in an athlete's test sample to administering or attempting to administer a prohibited substance or method to an athlete. As of December 19, 2008, the Code banned 192 performance-enhancing drugs, substances, and methods.
Similar to the definitional disputes the international community faced in the 1990s, national professional sports leagues in the U.S. approach anti-doping policy differently and independently of U.S. government regulation, WADA guidelines, and one another. This is not a big issue for WADA because the athletes participating in these leagues do not compete internationally, i.e. at the Olympics or World Championships. The leagues do not have the same list of banned substances or tests they require players to abide by, may not provide tests or sanctions for use of some prohibited substances, and negotiate their anti-doping policies with their respective players associations through collective bargaining.
In 2005, the United States House Committee on Oversight and Government Reform took an active interest on anti-drug policies in professional sports by opening an investigation into the matter following heightened media activity on steroid use in Major League Baseball (MLB). The use, possession, distribution, dispensing, or selling of steroids is a punishable federal offense under the Controlled Substances Act which, in addition to steroids, lists other performance-enhancing drugs and substances as Schedule III drugs. A series of Schedule III drugs were held, most notably with MLB, the National Football League (NFL), and the National Basketball Association (NBA). Each league's anti-drug policy was compared to that of the IOC, and each fell short of the IOC requirements. Response to the congressional investigation by sports league representatives resulted largely with push back and a "we can police our own" mentality, but the Committee felt differently and introduced the Clean Sports Act, one of six bills introduced that year in both chambers —addressing the need to adopt uniform national anti-drug policy standards among professional sports leagues that are consistent with, and as stringent as, those enforced by the USADA. While most of the bills were voted out of committee, none were enacted. As of 2013, professional sports leagues continue to negotiate their anti-doping policies privately through collective bargaining.